BIOMARKERS FOR DIAGNOSIS AND TREATMENT OF ENDOCRINE HYPERTENSION, AND METHODS OF… Application WO-2022171680-A1 World Intellectual Property Organisation (WIPO) 18 Aug 2022
THE ROLE OF PMCIC IN THE TUMOR MICROENVIRONMENT Application WO-2022013295-A1 World Intellectual Property Organisation (WIPO) 20 Jan 2022
P-cresol sulphate as a biomarker for healthy aging Application US-9322821-B2 United States of America 26 Apr 2016
PC-O 44:4—a biomarker for visceral adiposity Grant US-9261520-B2 United States of America 16 Feb 2016
PC-O 42:4—a biomarker for visceral adiposity Grant US-9261521-B2 United States of America 16 Feb 2016
Phenylacetylglutamine as a biomarker for healthy aging Application US-9201064-B2 United States of America 01 Dec 2015
PC-O 44:6—a biomarker for visceral adiposity Grant US-9201081-B2 United States of America 01 Dec 2015
PC-O 42:4 - A BIOMARKER FOR VISCERAL ADIPOSITY Application WO-2013186152-A1 World Intellectual Property Organisation (WIPO) 19 Dec 2013
PC-O 44:6 - A BIOMARKER FOR VISCERAL ADIPOSITY Application WO-2013186149-A1 World Intellectual Property Organisation (WIPO) 19 Dec 2013
PC-O 44:4 - A BIOMARKER FOR VISCERAL ADIPOSITY Application WO-2013186151-A1 World Intellectual Property Organisation (WIPO) 19 Dec 2013
PC-O 44:6 - A biomarker for visceral adiposity Application EP-2674760-A1 European Patent Office 18 Dec 2013
PC-O 42:4 - A biomarker for visceral adiposity Application EP-2674762-A1 European Patent Office 18 Dec 2013
PC-O 44:4 - A biomarker for visceral adiposity Application EP-2674761-A1 European Patent Office 18 Dec 2013